Artemis Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.3M Sell
573,420
-275,056
-32% -$23.4M 0.4% 86
2026
Q1
$73.1M Buy
848,476
+109,881
+15% +$9.86M 0.78% 51
2025
Q4
$64.5M Buy
738,595
+224,587
+44% +$17M 0.78% 47
2025
Q3
$29.4M Sell
514,008
-191,089
-27% -$11M 0.37% 86
2025
Q2
$41.6M Sell
705,097
-15,496
-2% -$1M 0.53% 67
2025
Q1
$52.7M Buy
720,593
+203,706
+39% +$16.8M 0.81% 45
2024
Q4
$42.8M Buy
516,887
+88,368
+21% +$6.97M 0.61% 58
2024
Q3
$30.7M Buy
+428,519
New +$30.3M 0.47% 74

Other funds holding GMED

Artemis Investment Management's GMED Position: Q2 2026 in Review

Artemis Investment Management reduced its Globus Medical (GMED) stake by 32% in Q2 2026, selling an estimated $23.4M and leaving 573,420 shares worth $45.3M. The position accounts for 0.4% of the portfolio, ranked #86.

Artemis Investment Management first reported a position in GMED in Q3 2024 and has held it in 8 quarters since. The position peaked at $73.1M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Artemis Investment Management held 573,420 shares of Globus Medical worth $45.3M as of Q2 2026.
  • Artemis Investment Management sold 275,056 Globus Medical shares in Q2 2026, an estimated $23.4M.
  • Globus Medical made up 0.4% of Artemis Investment Management's portfolio in Q2 2026, its #86 holding.
  • Artemis Investment Management first reported a position in Globus Medical in Q3 2024 and has held it in 8 quarters since.
  • Artemis Investment Management's Globus Medical position peaked at $73.1M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.